Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease breast cancer
Phenotype C0011860|type 2 diabetes mellitus
Sentences 6
PubMedID- 24338167 The aim of this study was to study the prevalence and clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of china for providing clinical guidance and prognosis appreciation for these patients.
PubMedID- 21133604 Our study aimed to compare the clinicopathologic characteristics of breast cancers in women with and without type 2 diabetes mellitus in china.
PubMedID- 24281091 The finding implicates a promising role of early administration of insulin-sensitizing therapy in prolonging survival of breast cancer patients with type 2 diabetes mellitus.
PubMedID- 26148588 Aim: we tend to explore the expression characteristics of proteins in igf/ir axis in breast cancer with type 2 diabetes mellitus (t2dm).
PubMedID- 26137275 Clinicopathological characteristics and prognosis of breast cancer patients with type 2 diabetes mellitus.
PubMedID- 26537234 Mammalian target of rapamycin (mtor) is activated by insulin and insulin-mediated breast cancer progression in patients with type 2 diabetes mellitus may be abrogated by inhibition of mtor [5].

Page: 1